From: Systematic review of melanoma incidence and prognosis in solid organ transplant recipients
First author (publication year) | Country | Graft type | Transplant years | Population size | Follow-up time |
---|---|---|---|---|---|
Jiang[8] | Canada | Heart | 1981–1998 | 1,703 | 10,369 person-years |
Webster[7] | Australia, New Zealand | Renal | 1963–2004 | 15,183 | 130,186 person-years; median 7.2 years |
Birkeland[10] | Nordica | Renal | 1964–1982 | 5,692 | 32,392 person-years |
Villeneuve[16] | Canada | Renal | 1981–1998 | 11,033 | 81,237 person-years |
Moloney[3] | Ireland | Renal | 1986–2001 | 1,558 | Median 5.7 years |
Bastiaannet[9] | Netherlands | Renal | 1989–2003 | 1,125 | 8165 person-years; mean 7.3 years |
Aberg[13] | Finland | Liver | 1982–2005 | 540 | 3222 person-years; mean 6.3 years |
Jiang[12] | Canada | Liver | 1983–1998 | 2,034 | 10,371 person-years |
Adami[6] | Sweden | Renal, liver, heart, lung | 1970–1997 | 5,931 | 40,360 person-years; mean 6.8 years |
Jensen[5] | Denmark | Renal, liver, heart, lung | 1977–2006 | 5,279 | 35,615 person-years; median 5 years |
Collett[4] | United Kingdom | Renal, liver, heart, lung | 1980–2007 | 37,617 | Median 16 years |
Engels[19] | United States | Renal, liver, heart, lung | 1987–2008 | 175,732 | 775,147 person-years |